1) labetalol
抑胺苄心定
2) labetalol
柳胺苄心定
1.
Analysis on the efficacy on intravenous labetalol in the treatment of emergent cases of hypertension;
静注柳胺苄心定治疗高血压急症的疗效分析
2.
Methods: Eligible mild and moderate essential hypertension patients were divided randomly into 2 groups: of which 29 received carvedilol (10 mg bid) and 25 received labetalol (50 mg bid) for 2 weeks.
方法 :随机单盲平行对照试验 ,符合条件的 5 4例轻中度原发性高血压患者随机分为 2组 :卡维地洛组 2 9例 ,柳胺苄心定组 2 5例。
3.
Aim:To compare the efficacy and side effect of domestic carvedilol and labetalol in the treatment of essential hypertension.
目的 :比较国产卡维地洛与柳胺苄心定治疗轻、中度原发性高血压患者的降压疗效和安全性。
3) labetatal
柳苄心胺
4) benzyl amine
苄胺
1.
1-benzyl-4-piperidone was synthesized from benzyl amine and methylacrylate via addition,Dieckmann condensation and hydrolytic decarboxylation.
以苄胺和丙烯酸甲酯为原料,经过加成、环合成盐、水解脱羧反应,合成了1-苄基-4-哌啶酮。
2.
The intermediate of new anti-hypertension drug OPC-21268, 3,4-dihydro-1-(4-piperidyl)-2(1H)-quinolinone, was synthesized from benzyl amine through six steps.
以苄胺为原料 ,经 6步反应得到新型抗高血压药OPC 2 12 6 8的中间体 3,4 二氢 1 (4 哌啶基 ) 2 (1H) 喹啉酮 ,总收率 13。
5) benzylamine
[,benzilə'mi:n]
苄胺
1.
Benzonitrile was selectively hydrogenated into benzylamine under mild conditions over activated amorphous nickel aluminium alloy catalyst which was prepared by rapidly quenching method.
由铜鼓快速淬冷法制备的非晶态NiAl合金催化剂经活化后用于催化苯甲腈加氢制苄胺的反应,考察了溶剂种类、苯甲腈初始浓度、催化剂用量、反应温度及反应压力等因素的影响,并测定了该催化加氢反应的表观活化能。
2.
1-Benzyl-2-pyrrolidone was prepared by the reaction of γ-butyrolactone and benzylamine catalyzed by phosphoric acid.
以磷酸作催化剂,γ-丁内酯和苄胺反应合成了1-苄基-2-吡咯烷酮,研究了反应条件对反应的影响,确定的最佳工艺条件为:n(γ-丁内酯)∶n(苄胺)∶n(磷酸)=1。
3.
Benzonitrile was catalytically bydroconverted to benzylamine on the modifiedRaney Ni catalysts.
采用改性骨架镍催化剂进行苯甲腈液相催化加氢制苄胺工艺研究,并考察了反应温度、压力、溶剂类型和组成、催化剂用量对苄胺收率的影响。
6) Benzylamine、.alpha.-Aminotoluene、Benzenemethanamine、(aminomethyl)benzene、(phenylmethyl)amine、(phenylmethyl)amine [qr]、aminotoluene [qr]、benzenemethanamine [qr]、monobenzylamine
苄胺、苯甲胺
补充资料：柳胺苄心定
分子式：C19H24N2O3
分子量：暂无
CAS号：36894-69-6
性质：暂无
制备方法：暂无
用途：抗高血压药。
分子量：暂无
CAS号：36894-69-6
性质：暂无
制备方法：暂无
用途：抗高血压药。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条